Drugs in Discovery
McDonnell Douglas electrophoresis project on Discovery shuttle flight was scheduled to begin on Aug. 31, one day into the shuttle flight. McDonnell Douglas engineer Charles Walker is accompanying flight crew to monitor the machine as it performs up to 80 hours of continuous separation. The company explains that Walker will test the electrophoresis in process. Walker "also has the necessary tools and spare parts on board, including a variety of pumps and filters for in flight maintenance." Frozen extract product will be delivered to Ortho Pharmaceutical for animal testing
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”